Atyr Pharma Inc (ATYR)

$0.83 +0.06 (7.39%)
Market Cap 69.12M
Revenue (ttm) 240,000.00
Net Income (ttm) -64.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -26,675.00%
Debt to Equity Ratio 0.00
Volume 3,227,500
Avg Vol 6,728,418
Day's Range N/A - N/A
Shares Out 97.99M
Stochastic %K 78%
Beta 0.57
Analysts Sell
Price Target $5.20

Company Profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitiv...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 731 8389
Fax: 858 731 8394
Address:
10240 Sorrento Valley Road, Suite 300, San Diego, United States
trader2sde
trader2sde Dec. 5 at 2:30 AM
$ATYR Dr Prasad back at FDA may help here...
0 · Reply
trader2sde
trader2sde Dec. 5 at 2:27 AM
$ATYR restarting a position step by step. potential for a few bucks with new FDA presentation and discussions. shorters covering too.
0 · Reply
Darling69
Darling69 Dec. 4 at 5:57 PM
$ATYR why the heck is this trafedy pumping?
1 · Reply
alexx013
alexx013 Dec. 4 at 5:27 PM
$ATYR dollar soon
1 · Reply
TraderNice
TraderNice Dec. 4 at 2:46 PM
$ATYR Today’s FDA Environment. The FDA has absolutely become more flexible and supportive, especially when: First, the disease has high unmet need, the therapy has clean safety and the previous study showed positive secondary endpoints. Now, the failure was due to trial design-not drug biology. Also, the company comes prepared with a sound redesign proposal
1 · Reply
__Godzilla__
__Godzilla__ Dec. 4 at 2:40 PM
$ATYR "Majority view (of experts) is that the dataset is demonstrating clinical benefit" and will engage the FDA in 2026. If this is true, I would not want to short this stock.
0 · Reply
MakeM0ney_444
MakeM0ney_444 Dec. 4 at 2:14 PM
$QCLS I think pharma bro is a scum bag but he was dead on about $ATYR where I lost a big bag. In for 100 shares of this strictly as a gamble @ $4.16. $100 would be amazing
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 6:33 AM
Hedge Alert Live - Protect Your Portfolio Contract: $ATYR $5.00 Put · DEC 12, 2025 Exp Entry Price: $4.25 - $5.00 Exit Price Target: $10.12 Profit Margin: +138% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Dec. 4 at 3:17 AM
💎 LiquidTheta® Live Actionable Trade Asset: $ATYR Contracts: $ATYR January 15, 2027 $1 Calls Scale in: $0.35- $0.43 Scale out: $1.36-$2.33 Profit Potential : 383% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
OnlyBuyMoreShareSqueezes
OnlyBuyMoreShareSqueezes Dec. 3 at 6:54 PM
$ATYR I also listened to it, if you are investing here, i would recommend listening to it, for sure we are oversold, we will be back at 6 dollars , the person asking him questions also reiterated that there is plenty of analyst still holding their buy rating on this stock, If you search up Piper Sandler , you will see they connect huge institutional investors, this meeting was bullish, nexts steps is talks with the FDA coming early 2026. Buy shares and hold.
0 · Reply
Latest News on ATYR
ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

Dec 4, 2025, 2:44 PM EST - 8 hours ago

ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Dec 4, 2025, 10:56 AM EST - 12 hours ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

Dec 4, 2025, 7:48 AM EST - 15 hours ago

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit – ATYR

Dec 3, 2025, 4:21 PM EST - 1 day ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit – ATYR

ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Dec 3, 2025, 9:22 AM EST - 1 day ago

ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Dec 1, 2025, 6:32 PM EST - 3 days ago

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

The Short List — Top 10 Most Shorted Stocks Right Now

Nov 26, 2025, 11:34 AM EST - 8 days ago

The Short List — Top 10 Most Shorted Stocks Right Now

CMBM HIMS HTZ LCID NTLA REPL SOC

aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug's Efficacy Moves Forward -- Hagens Berman

Nov 25, 2025, 4:08 PM EST - 9 days ago

aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug's Efficacy Moves Forward -- Hagens Berman

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYR

Nov 20, 2025, 8:45 AM EST - 14 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYR

ATYR INVESTOR NOTICE: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman

Nov 18, 2025, 2:03 PM EST - 16 days ago

ATYR INVESTOR NOTICE: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman

aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman

Nov 11, 2025, 9:23 AM EST - 23 days ago

aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman

aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 10, 2025, 8:00 AM EST - 24 days ago

aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference

aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update

Nov 6, 2025, 4:01 PM EST - 4 weeks ago

aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update

ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ATyr Pharma

Nov 4, 2025, 11:49 AM EST - 4 weeks ago

ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ATyr Pharma

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Oct 30, 2025, 11:33 AM EDT - 5 weeks ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit - ATYR

Oct 30, 2025, 8:45 AM EDT - 5 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit - ATYR

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Oct 28, 2025, 9:34 AM EDT - 5 weeks ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

ATYR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Oct 23, 2025, 1:28 PM EDT - 6 weeks ago

ATYR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman

Oct 22, 2025, 4:49 PM EDT - 6 weeks ago

aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman

Oct 9, 2025, 1:50 PM EDT - 2 months ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower – Hagens Berman

Oct 3, 2025, 2:32 PM EDT - 2 months ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower – Hagens Berman

Ethos Technologies Targets IPO Amid Positive Insurance Offerings

Sep 30, 2025, 2:59 PM EDT - 2 months ago

Ethos Technologies Targets IPO Amid Positive Insurance Offerings

LIFE

aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT™ Study in Late-Breaking Oral Abstract at the European Respiratory Society (ERS) Congress 2025

Sep 30, 2025, 5:30 AM EDT - 2 months ago

aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT™ Study in Late-Breaking Oral Abstract at the European Respiratory Society (ERS) Congress 2025

Ethos Files Registration Statement for Proposed Initial Public Offering

Sep 26, 2025, 1:50 PM EDT - 2 months ago

Ethos Files Registration Statement for Proposed Initial Public Offering

LIFE

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT™ Study Failure Drives Shares 80% Lower -- Hagens Berman

Sep 23, 2025, 9:22 AM EDT - 2 months ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT™ Study Failure Drives Shares 80% Lower -- Hagens Berman

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman

Sep 22, 2025, 11:08 AM EDT - 2 months ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman

trader2sde
trader2sde Dec. 5 at 2:30 AM
$ATYR Dr Prasad back at FDA may help here...
0 · Reply
trader2sde
trader2sde Dec. 5 at 2:27 AM
$ATYR restarting a position step by step. potential for a few bucks with new FDA presentation and discussions. shorters covering too.
0 · Reply
Darling69
Darling69 Dec. 4 at 5:57 PM
$ATYR why the heck is this trafedy pumping?
1 · Reply
alexx013
alexx013 Dec. 4 at 5:27 PM
$ATYR dollar soon
1 · Reply
TraderNice
TraderNice Dec. 4 at 2:46 PM
$ATYR Today’s FDA Environment. The FDA has absolutely become more flexible and supportive, especially when: First, the disease has high unmet need, the therapy has clean safety and the previous study showed positive secondary endpoints. Now, the failure was due to trial design-not drug biology. Also, the company comes prepared with a sound redesign proposal
1 · Reply
__Godzilla__
__Godzilla__ Dec. 4 at 2:40 PM
$ATYR "Majority view (of experts) is that the dataset is demonstrating clinical benefit" and will engage the FDA in 2026. If this is true, I would not want to short this stock.
0 · Reply
MakeM0ney_444
MakeM0ney_444 Dec. 4 at 2:14 PM
$QCLS I think pharma bro is a scum bag but he was dead on about $ATYR where I lost a big bag. In for 100 shares of this strictly as a gamble @ $4.16. $100 would be amazing
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 6:33 AM
Hedge Alert Live - Protect Your Portfolio Contract: $ATYR $5.00 Put · DEC 12, 2025 Exp Entry Price: $4.25 - $5.00 Exit Price Target: $10.12 Profit Margin: +138% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Dec. 4 at 3:17 AM
💎 LiquidTheta® Live Actionable Trade Asset: $ATYR Contracts: $ATYR January 15, 2027 $1 Calls Scale in: $0.35- $0.43 Scale out: $1.36-$2.33 Profit Potential : 383% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
OnlyBuyMoreShareSqueezes
OnlyBuyMoreShareSqueezes Dec. 3 at 6:54 PM
$ATYR I also listened to it, if you are investing here, i would recommend listening to it, for sure we are oversold, we will be back at 6 dollars , the person asking him questions also reiterated that there is plenty of analyst still holding their buy rating on this stock, If you search up Piper Sandler , you will see they connect huge institutional investors, this meeting was bullish, nexts steps is talks with the FDA coming early 2026. Buy shares and hold.
0 · Reply
SoManyRoads
SoManyRoads Dec. 3 at 6:21 PM
$ATYR Just listened to the Piper Sandler chat. Good explanation for the timing of presenting to the FDA.
1 · Reply
Bestbet247
Bestbet247 Dec. 3 at 6:18 PM
$AMZE Playing these 3 stocks heavily $AMZE $ATYR $RCAT Lets go Santa clause rally start now!!!!
1 · Reply
OnlyBuyMoreShareSqueezes
OnlyBuyMoreShareSqueezes Dec. 3 at 5:42 PM
$ATYR BUY SHARES AND HOLD LONG !
1 · Reply
Houzehero
Houzehero Dec. 3 at 5:22 PM
$ATYR FDA path is viable, KOL backing, the drug works. https://investors.atyrpharma.com/events/event-details/piper-sandler-37th-annual-healthcare-conference
1 · Reply
Bestbet247
Bestbet247 Dec. 3 at 4:32 PM
$ATYR I didn’t ride it down but I’m riding it up.
0 · Reply
TraderNice
TraderNice Dec. 3 at 3:55 PM
$ATYR Lawsuits? Fraud? no fraud in this case - just shareholder litigation tied to disclosure and expectations. In biotech, these lawsuits are almost routine when a pivotal trial fails or approval is delayed.
1 · Reply
Tabrezmohiuddin
Tabrezmohiuddin Dec. 3 at 3:00 AM
$ATYR 0.7542 +0.0488 +(6.92%)
1 · Reply
Stokwits
Stokwits Dec. 2 at 6:17 PM
$ATYR Conference happening? Looking for some news.
0 · Reply
Haifischflosse
Haifischflosse Dec. 2 at 8:58 AM
$ATYR heute ist die gesundheitskonferenz wo man sich auch mit investoren trifft.es gibt einen webcast dazu. eventuell interessante neuigkeiten für atyr.ich hoffe der kurs läuft dieses jahr noch an die 1 dollarmarke.dort hat der ceo ja auch fett gekauft.von januar bis märz 2026 ist dann alles möglich.es wird auf die entscheidung der fda ankommen.
2 · Reply
idunnobro
idunnobro Dec. 2 at 4:32 AM
$ATYR 🦗🦗🦗
0 · Reply
OnlyBuyMoreShareSqueezes
OnlyBuyMoreShareSqueezes Dec. 2 at 1:49 AM
$ATER $ATYR $WLFI.X $MEW.X I block bears and continue buying . I tend to check in these chats from time to time to see what the word is from bulls . I’m silent at times BUT NOT SELLING AND ONLY BUYING MORE ! We have time to make money , deposit , increase holdings ,and chill . It’s a long term plan ✅ we have plenty of positive things to look forward to
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Dec. 2 at 12:38 AM
💎 LiquidTheta® Live Actionable Trade Asset: $ATYR Contracts: $ATYR January 15, 2027 $1 Calls Scale in: $0.33- $0.40 Scale out: $1.27-$2.17 Profit Potential : 88% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply